Research and Reviews: A Journal of Toxicology Open for submissions
Artificial Intelligence in Drug Delivery
Special issue — call for papers.
- Journal
- Research and Reviews: A Journal of Toxicology
Scope
Interventional pharmacology is one of medicine's strong weapons against diseases. These drugs, be that as they may, can result in harmful side impacts and must be closely observed. Pharmacovigilance is the field of science that screens recognizes, and avoids adverse drug reactions (ADRs). Security efforts start amid the advancement handle, utilizing in vivo and in vitro studies, proceed through clinical trials, and amplify to the postmarketing observation of ADRs in real-world populaces. The utilization of artificial intelligence (AI) has been expanding in different segments of society, especially the pharmaceutical industry. In this survey, we highlight the utilization of AI in different divisions of the pharmaceutical industry, counting medicate disclosure and advancement, drug repurposing, making strides in pharmaceutical efficiency, and clinical trials, among others; such utilization decreases the human workload as well as accomplishing targets in a brief period. With the consideration of AI within the manufacturing of pharmaceutical products, personalized drugs with the specified measurements, discharge parameters, and other required perspectives can be manufactured agreeing to patients' needs required. Utilizing the most recent AI-based advances will not as it was speeding up the time required for the items to come to the advertising, but will too make strides in the quality of items and the general security of the production process, and give superior utilization of accessible assets alongside being cost-effective, subsequently expanding the significance of automation.
Keywords: Adverse drug reactions (ADRs), Artificial Intelligence (AI), Drugs, Pharmaceutical, Diseases
Papers in this collection
- The papers will be listed here as they are published.